FASPRIN - aspirin tablet, orally disintegrating 
Nobel Laboratories, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active Ingredient (In Each Tablet)

Aspirin 81 mg

Purpose

Pain Reliever/Fever Reducer

Uses

For temporary relief of minor aches and pains

Warnings:

Reye's syndrome: Children and teenagers should not use this medicine
for chicken pox or flu symptoms before a doctor is consulted about
Reye's syndrome, a rare but serious illness reported to be associated
with aspirin.

Alcohol Warning:
If you consume 3 or more alcoholic drinks every day, ask
your doctor whether you should take aspirin or other pain relievers/fever
reducers. Aspirin may cause stomach bleeding.

  • If you are allergic to aspirin
  • With any other pain reliever/fever reducer
  • If you have ever had an allergic reaction to any other pain reliever/fever reducer
  • For pain for more than 10 days or for fever for more than 3 days unless directed by a doctor
  • With any other product containing aspirin

Ask doctor before using if you have:

  • Asthma
  • Bleeding problems
  • Stomach problems (such as heartburn, upset stomach or stomach pain) gastric ulcers

Ask a doctor or pharmacist before use if you are taking a prescription drug for:

  • Anticoagulation (thinning of blood)
  • Diabetes
  • Gout
  • Arthritis

Stop use and ask a doctor if:

  • Ringing in the ears or loss of hearing occurs
  • Pain or fever persists or gets worse
  • New symptoms occur
  • Redness or swelling is present

If pregnant or breast-feeding baby,

ask a health professional before use. IT IS ESPECIALLY IMPORTANT NOT TO USE ASPIRIN DURING THE LAST 3 MONTHS OF PREGNANCY UNLESS SPECIFICALLY DIRECTED TO DO SO BY A DOCTOR BECAUSE IT MAY CAUSE PROBLEMS IN THE UNBORN CHILD OR COMPLICATIONS DURING DELIVERY.

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions

Directions: Remove tablet from backing by bending at perforation and
peeling back cover. Place tablet on tongue and allow saliva to dissolve the
tablet for rapid absorption.
Adults: Take 1 tablet daily, do not exceed 36 tablets in 24 hours, or as
directed by a doctor. Children: Consult a doctor.

Inactive Ingredients:

Citric Acid, Crospovidone, D and C Yellow #10, Flavor, Glucosamine Sulfate-K, Mannitol, Sodium Stearyl Fumarate, Sorbitol, Sunnette K, Zinc Gluconate

Manufactured for: Nobel Laboratories, LLC

3413 Spanish Oak Drive  Austin, TX 787314

www.NobelLabs.com

Store Product Below 90 degrees F. Protect from heat, light and moisture.

U.S Patents 6,596,708 / 6,930,099 and Patents Pending

Package Label Section

image of carton label

FASPRIN 
aspirin tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10597-559
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN81 mg
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
CROSPOVIDONE (UNII: 68401960MK)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
GLUCOSAMINE (UNII: N08U5BOQ1K)  
MANNITOL (UNII: 3OWL53L36A)  
SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)  
SORBITOL (UNII: 506T60A25R)  
ZINC GLUCONATE (UNII: U6WSN5SQ1Z)  
Product Characteristics
Coloryellow (yellow) Scoreno score
ShapeROUND (Round) Size9mm
FlavorImprint Code F
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10597-559-0530 in 1 BOX
2NDC:10597-559-06100 in 1 BOX
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34309/20/2006
Labeler - Nobel Laboratories, LLC (022735189)
Establishment
NameAddressID/FEIBusiness Operations
Avema Pharma Solutions804087794manufacture

Revised: 11/2010
Document Id: 5108bdca-1454-4353-b55f-e31da8ed4f4f
Set id: 73859ea9-01a0-4c3d-97d4-17b9d3378899
Version: 1
Effective Time: 20101130
 
Nobel Laboratories, LLC